Simvastatin 97.0%(HPLC)
97.0%(HPLC)
Properties
| Vapour pressure | 0.0±3.5 mmHg at 25℃ |
| Assay Purity | >97%(HPLC) |
| Refractive index | 1.53 |
| B pt. | 564.9℃ at 760 mmHg |
| M pt. | 134℃ |
| Density | 1.11 g/cm3 |
Safety Information
| Hazard Statement(s) | H361d |
| Precautionary Statement | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| Symbol |
|
| Signal word | Warning |
| Flash point | 184.8℃ |
| Storage Temp. | 0-6℃ |
| Storage Class | 9 |
| Packaging | Poly Bottle |
| UN Number | 3077 |
Description
Recommended products
2-Chloro-NN-Diethylacetamide 97%
Application
Simvastatin has been used as an inhibitor of HMG CoA reductase (HMGCR) to study its effects on epithelial to mesenchymal transition (EMT) and the prognosis of patients with lung adenocarcinoma in in vivo studies to test its effect on brain tumorinitiating cells (BTIC) viability and cell proliferation to study the role of adenosine triphosphate (ATP)-binding cassette transporter A7 in phagocytosis of Jurkat cells to study the effect on endothelial dysfunction and inflammation in mice.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Simvastatin is a prodrug. Simvastatin is a semisynthetic derivativeanalog of lovastatin. Simvastatin is insoluble in water but is soluble in polar organic solvents.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |